| Tag | Content |
|---|
EnhancerAtlas ID | HS010-02547 |
Organism | Homo sapiens |
Tissue/cell | B_cell_blood |
Coordinate | chr2:137010880-137011660 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxa2 | MA0047.2 | chr2:137011026-137011038 | CCTGTGTAAACA | - | 6.14 | | Myog | MA0500.1 | chr2:137011440-137011451 | AACAGCTGCAG | + | 6.02 | | Tcf12 | MA0521.1 | chr2:137011440-137011451 | AACAGCTGCAG | + | 6.62 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09631 | chr2:137010582-137014917 | CD14 | | SE_10274 | chr2:137010741-137014409 | CD19_Primary | | SE_11065 | chr2:137010304-137014964 | CD20 | | SE_61425 | chr2:136945577-137039880 | Toledo | | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I136253 | chr2 | 137010941 | 137014177 |
|
Enhancer Sequence | AGTAAGAAAA TGATTTCTTA CTCCTATTTC TGTCTTGGGG AATTGATGCT AACTTGAAGA 60
TTCATAGACA TGTACTTTCT GGTGGGGACA GGATCTTTGA GAACAACTGG TCAAACTTCA 120
TCTGGTTTCA GAATCTCTTC TATGGCCCTG TGTAAACACC TGCCCTGATG TGGATCTCTA 180
ACTACTGAGA CTGCCCCCAG ATGGGACTCT TGGGAAGTTA TTGTTTACTT GAGTTGAAAT 240
CAGCCTCCTG CTGGCTTCAG GCCATTGGTC CCAGTTCTGT TCTGCCATAC TTCAGATTCT 300
CACCATCTTG GAGCTGCTGG GAACCAGGGG CCCTGGGGTC ATCCTTGCAA GGGAACTAGG 360
GAAGAAAGAG GAAGCTGAGG GGCTGGAGCC AACCGTAAGG CGTTCCTCTT TGGGAAGGCT 420
GGCTTGTGAT GGGACTTGCC AGGACCAGCA TGCTGAGAGG AGGAAGCCAG CTCTCAGGTC 480
AAGATTCCGT TGATGTGGAA CAAACTATAA CCCTGCGCCG TTGCTTTCCC AGGCCTCACT 540
TCCCCAAACA GGGGCACGTG AACAGCTGCA GTGGCCTGGT GGCAGCATGC TGGGATCCTT 600
CAGGCCAGGC CAGCAAAAGG GTAAAATCTG GGCCAGTGGG TACCCTCATA GGGACTCTCC 660
AGGCTGCCTT CCTCTTCCAG GTCTTCTGTG AAATTAGCTG GAAAAGGAGA TCACATGCCT 720
GATTCCCCTT TATCCCAGCA AGCCTGGAAA ACAAAGTCCA GCCCCAGTCA AAAGCTTCCT 780
|
